UPMC Enterprises has participated in a $20m series A round for healthcare data management company Smile CDR.

MIT spinout Iterative Scopes has now raised $43.5m altogether from investors including Eli Lilly and Johnson & Johnson.

MIT spinout Quaise has added $12m to its coffers, having previously collected seed funding from The Engine.

A range of strategic investors have backed a series A5 round for the clean nuclear energy technology developer that leverages OSU research.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Co-founded by Stanford researchers, IgGenix is working on therapies that address severe allergies.

The gene editing technology developer is the latest spinout emerging out of the lab of David Liu at Broad Institute.

The precision oncology platform is based on research by Duke and Hubrecht Institute faculty and the cash will fund technology development and clinical studies.

VIB and V-Bio Ventures have both participated in a series A round for Muna Therapeutics, the result of a merger of two recent spinouts.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.